Inventiva S.A. Sponsored ADR

IVA Healthcare Biotechnology

Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.

2.94 0.17 −5.47%
Market cap
$740.0M
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
−1.36
Beneish M
−7.91
Dividend safety
n/a
Older periods Jun '23 Jun '24 Jun '25 Jun '26
ROE

+8 more TTM periods

(299.62%) 0.00% 0.00% 0.00%
ROA
(134.83%) 0.00% 0.00% 0.00%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(611.61%) 0.00% 0.00% 0.00%
Average Days of Receivables
134.41 0.00 0.00 0.00
Free Cash Flow per Share
0.00 0.00 0.00 —
Free Cash Flow
(128.69) (105.47) (137.54) —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 30 Sep 2026